Exact Sciences’ Executives, Colon Cancer Challenge Leaders To Ring Nasdaq Opening Bell

Exact Sciences Corp. (Nasdaq: EXAS) today announced that Kevin T. Conroy, the company’s president and chief executive, and the company’s management team will ring the NASDAQ Stock Market Opening Bell on Tuesday, March 20.

Thomas A. Weber, M.D., founder and president of the Colon Cancer Challenge Foundation, and Antoine Dove, its national spokesman and former “Biggest Loser” contestant, will join the Exact Sciences' executives. They will ring the opening bell in honor of National Colorectal Cancer Awareness Month, which is observed each year in March.

Colorectal cancer is the second-leading cause of cancer deaths, according to the American Cancer Society. Almost 150,000 new cases of colorectal cancer are diagnosed and approximately 50,000 people die from the disease every year.

“We are proud to be a partner of the Colon Cancer Challenge Foundation as we promote regular screening for the disease during Colorectal Cancer Awareness Month,” Mr. Conroy said. “Colorectal cancer is one of the most preventable cancers, but it must be caught early. Awareness programs like those run by the foundation and improvements in screening methods like those Exact is advancing are both important tools in reducing colorectal cancer mortality.”

“Too often in my practice, I have seen the devastating consequences to patients and their families of failing to get screened properly for colorectal cancer,” Dr. Weber said. “That’s why I founded the foundation: to challenge people to get the facts about colorectal cancer, talk to their family and doctor about the disease and, most important, to get screened. We are pleased to commemorate Colorectal Cancer Awareness Month with Exact Sciences and join them in offering our challenge to get screened.”

The ceremony, which is being held at the Nasdaq MarketSite in New York, will begin at 9:15 a.m. EST and culminate with the ringing of the Opening Bell at 9:30 a.m. Before ringing the bell, Mr. Conroy will make brief remarks about the company and its commitment to the early detection of colorectal cancer.


A live webcast of the opening bell ceremony will be available by following this link: http://www.nasdaq.com/about/marketsitetowervideo.asx.

Feed Information
Fiber Line (Encompass Waterfront): 4463
Gal 3C/06C 95.05 degrees West
18 mhz Lower
DL 3811 Vertical
FEC 3/4
SR 13.235
DR 18.295411
MOD 4:2:0

For more information, please contact Jennifer Knapp at 212-401-8916 or the NASDAQ Broadcast Control Room at 646-441-5236.


Mr. Conroy will be available for interviews following the opening bell ceremony. Exact’s stool-based DNA screening test is progressing through its clinical trial at 60 sites across the country. The company anticipates completing the trial and beginning its submission to the U.S. Food and Drug Administration by the end of 2012. Interview requests should be directed to the company’s manager of corporate communications, Cara Tucker, at 608-284-5735.


To obtain a high-resolution photograph of the market opening ceremony, please go to http://www.nasdaq.com/reference/marketsite_events.stm and click on the market open of your choice.

Please note: All times referenced in this news release are Eastern Standard Time.

About Exact Sciences Corp.

Exact Sciences Corp. is a molecular diagnostics company focused on colorectal cancer. The company has exclusive intellectual property protecting its non-invasive, molecular screening technology for the detection of colorectal cancer. Stool-based DNA technology is included in the colorectal cancer screening guidelines of the American Cancer Society and the U.S. Multi-Society Task Force on Colorectal Cancer. For information about the company, please visit our web site at www.exactsciences.com.

About the Colon Cancer Challenge Foundation

The CCCF is dedicated to A World Without Colorectal Cancer through public awareness, prevention, screening and research. The Challenge continues to inform, educate and stress the importance of colorectal cancer awareness, screening and prevention, and the simple fact that it is, for the most part, preventable, treatable and beatable if diagnosed early using the screening techniques recommended by the American Cancer Society (ACS) and Centers for Disease Control (CDC). CCCF will celebrate the 9th Annual NY Colon Cancer Challenge ® on April 1, 2012, in New York’s Central Park. For additional information on CCCF, please visit www.coloncancerchallenge.org.

Copyright Business Wire 2010